Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
August 21, 2009
IN THIS ISSUE
Value of outsourcing
FDA warning letters
Drug label requirements
Green chemistry
More...

Businesses neglect to measure value of outsourcing
Only 43% of European Chief Financial Officers (CFOs) and Chief Information Officers (CIOs) have tried to calculate the impact of outsourcing on their company, and of those that have tried, only 1 in 5 are confident in their sums, according to a study by Cognizant. More...

Warning letter enforcement begins in September
The FDA has announced a new programme regarding the issuance of warning letters to the pharmaceutical industry. More...

FDA urged to demand greater transparency
Researchers from a university in the US are urging the FDA to demand that drug manufacturers state how new medications compare with similar treatments on product labels. More...

Industry considers green-chemistry standards
An initiative to develop consensus-based industry standards to identify and define green chemicals and process technologies is underway in the US. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's latest discussion on LinkedIn on green pharmaceutical packaging. More...

Amcor makes a move for Alcan Packaging
Amcor (Australia) has made an offer of $2025 million for parts of Alcan Packaging (France), including the company's global pharmaceuticals division. More...

The first aptamer-liposome delivery system
Researchers at the University of Illinois (US) have developed a cancer drug delivery system that reportedly kills target tumour cells, spares healthy cells and has effects that can be reversed to halt potentially hazardous side effects. More...

Key Topic Updates
September events
Science@BPC (UK)
Validation of computer systems (Ireland)
European Pulsed Power Conference 2009 (Switzerland)
Submit your event
 
Ingredients
Why we need mass serialization — now!
Substandard APIs: we must tackle the problem together
Orally disintegrating tablets: the path to improved patient compliance and enhanced life cycle management
More ingredients articles
 
Manufacturing and processing
Nanotechnology: the next silver bullet?
Thinking of theranostics?
Bioanalytical laboratories: facing future challenges
More manufacturing and processing articles

Key Topic Updates

Survey
Do you believe that most pharmaceutical manufacturers will eventually adopt microreactor technology for continuous, large-scale processing
  Yes 71%
  No 29%

This week we would like to know...

Should a drug label state how the medicine compares with similar treatments?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected]or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.